United States · FDA National Drug Code directory
levocetirizine dihydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68391-955_6098f8c4-4502-287f-cd05-06e17d773116
- Product NDC
- 68391-955
- Form
- TABLET, COATED
- Composition / generic term
- levocetirizine dihydrochloride
- Labeler
- BJWC (Berkley & Jensen / BJ'S)
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200624
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOCETIRIZINE DIHYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BOTTLE in 1 PACKAGE (68391-955-11) / 55 TABLET, COATED in 1 BOTTLE (68391-955-55) · 68391-955-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →